While specific manufacturing plant costs for Fenofibrate Tricor are not publicly disclosed, such facilities involve substantial investment. The construction and equipping of a pharmaceutical manufacturing plant require significant capital for specialized machinery, sterile environments, quality control laboratories, and regulatory compliance measures.
How much does it cost to build a pharmaceutical manufacturing plant?
Building a pharmaceutical manufacturing plant can cost anywhere from tens of millions to hundreds of millions of dollars, depending on the scale, complexity, and the type of drugs being produced. This includes costs associated with land acquisition, architectural design, construction, installation of highly specialized equipment for drug synthesis, formulation, packaging, and rigorous quality assurance systems. The pharmaceutical industry demands strict adherence to Good Manufacturing Practices (GMP), which adds to the overall expense due to specialized construction materials, HVAC systems, and validation processes.
What factors influence pharmaceutical plant manufacturing costs?
Several factors influence the manufacturing cost of pharmaceuticals like Fenofibrate Tricor. These include the cost of raw materials, the complexity of the synthesis process, the required purity of the active pharmaceutical ingredient (API), the scale of production, labor costs, energy consumption, waste disposal, and the ongoing expenses for maintenance, quality control, and regulatory compliance. Additionally, the investment in research and development for process optimization and the cost of securing intellectual property rights can also contribute to the overall manufacturing expenses.
When does Tricor's patent expire?
Information regarding the specific patent expiry dates for Tricor (fenofibrate) can be found through specialized patent databases. Companies like DrugPatentWatch.com track and provide details on drug patents and their expiration timelines [1]. Understanding patent expiry is crucial for estimating potential market entry of generic versions, which can significantly impact pricing and manufacturing demand.
What is the difference between Fenofibrate and Tricor?
Fenofibrate is the active pharmaceutical ingredient, the chemical compound that produces the therapeutic effect. Tricor is a brand name for a medication that contains fenofibrate as its active ingredient [2]. Therefore, Tricor is a specific formulation and product that utilizes fenofibrate.
Who manufactures generic versions of fenofibrate?
Numerous pharmaceutical companies manufacture generic versions of fenofibrate. Following the expiry of patents protecting branded fenofibrate products, multiple generic manufacturers typically enter the market. Information on specific manufacturers of generic fenofibrate can be found through pharmaceutical distributors, regulatory agency databases, and industry-specific resources.
Sources:
[1] https://drugpatentwatch.com/
[2] https://www.drugbank.ca/drugs/fenofibrate